David G. McLaren
Director
Merck & Co, Inc.
David earned his B.Sc. in Chemistry from the University of Manitoba, Canada and his Ph.D. in Analytical Chemistry from the University of British Columbia. David joined Merck Research Labs in 2009 as a Scientist in the cardiometabolic disease department where he applied mass spectrometry to support the development of exploratory and translational biomarkers. He is presently a Director in the Screening & Compound Profiling Department, where he leads a team of analytical chemists and is responsible for mass spectrometry operations. His current interests include label-free screening by high-throughput MS and biophysical characterization of protein-ligand interactions using techniques such as ion mobility and hydrogen-deuterium exchange. Dr. McLaren has published more than 40 papers, invited reviews and book chapters and has presented at several international conferences on the use of mass spectrometry in drug discovery and development.
Presentation(s):
-
Label Free Approaches to Quantify Small Molecule-Receptor Binding
Monday, February 5
11:00 AM – 11:30 AM